Online learning (Target Ovarian Cancer and BMJ Learning) - audio module
Ovarian cancer: recognising early symptoms in primary care was commissioned from BMJ Learning by Target Ovarian Cancer.
This audio module looks at ovarian cancer in primary care and was recorded in December 2011. It is chaired by Graham Easton, a GP in west London and the Department of Primary Care and Public Health at Imperial College. In it two clinicians with a special interest in this area, Dr Vicki Barber (a GP in Northamptonshire) and Mr Jed Hawe (consultant obstetrician and gynaecologist, local gynaecological cancer lead, Countess of Chester NHS Foundation Trust, and a member of the NICE guideline development group) , examine the importance of early diagnosis and prognosis, the risk factors, and the signs and symptoms to look out for. They also discuss further investigations and how to interpret and convey the results to patients in a primary care setting. The podcast lasts around 20 minutes.
On completion of this module users should know:
- Patients do have symptoms in early stages of the disease
- To consider ovarian cancer when patients present with suggestive symptoms
- The typical red flag signs to look out for
- The typical patterns of symptoms
- How to assess and test patients with possible ovarian cancer
- How to interpret results and next steps.
This resource was developed independently by Target Ovarian Cancer and BMJ Learning and not directly from the NICE guidance. The content reflects the NICE guidance, with additional information, and facilitates its implementation. NICE has undertaken a check of the resource at the point at which this link was published and is satisfied that it broadly supports the guidance. However NICE is unable to confirm that all of the content at any one time accurately reflects the guidance, and therefore no guarantees are given either by NICE in this regard. If an individual clinician has any queries or concerns about the relationship between NICE guidance and this educational resource they should always refer to the original guidance published by NICE, and this should in all cases be regarded as the only definitive statement of the guidance.
This page was last updated: